2017 Form 10-K Financial Statement

#000143774917020614 Filed on December 13, 2017

View on sec.gov

Income Statement

Concept 2017 2016 Q3 2016
Revenue $20.31M $4.900M $16.36M
YoY Change 24.16% 11.11% -2.52%
Cost Of Revenue $10.04M $2.590M $8.689M
YoY Change 15.49% 15.63% 5.25%
Gross Profit $10.28M $2.300M $7.672M
YoY Change 33.98% 5.99% -10.05%
Gross Profit Margin 50.6% 46.94% 46.89%
Selling, General & Admin $8.586M $1.570M $6.877M
YoY Change 24.86% 38.94% 30.22%
% of Gross Profit 83.54% 68.26% 89.64%
Research & Development $2.500M $600.0K $2.388M
YoY Change 4.69% 30.43% 17.72%
% of Gross Profit 24.32% 26.09% 31.13%
Depreciation & Amortization $153.3K $40.00K $160.9K
YoY Change -4.76% -33.33% -30.74%
% of Gross Profit 1.49% 1.74% 2.1%
Operating Expenses $11.09M $2.170M $9.265M
YoY Change 19.66% 37.34% 26.75%
Operating Profit -$807.7K $130.0K -$1.593M
YoY Change -49.3% -77.97% -230.67%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $128.6K $30.00K $125.5K
YoY Change 2.46% 0.0% 3.0%
Pretax Income -$679.2K $160.0K -$1.468M
YoY Change -53.73% -74.19% -209.44%
Income Tax $197.6K $680.0K -$186.2K
% Of Pretax Income 425.0%
Net Earnings -$876.8K -$510.0K -$1.282M
YoY Change -31.59% -105.69% -113.23%
Net Earnings / Revenue -4.32% -10.41% -7.83%
Basic Earnings Per Share -$0.03 -$0.04
Diluted Earnings Per Share -$0.03 -$16.04K -$0.04
COMMON SHARES
Basic Shares Outstanding 31.86M 31.97M
Diluted Shares Outstanding 31.97M

Balance Sheet

Concept 2017 2016 Q3 2016
SHORT-TERM ASSETS
Cash & Short-Term Investments $17.12M $16.40M $16.40M
YoY Change 4.39% -16.2% -16.2%
Cash & Equivalents $12.76M $13.47M $13.47M
Short-Term Investments $4.360M $2.940M $2.940M
Other Short-Term Assets $980.0K $600.0K $600.0K
YoY Change 63.33% 5.26% 5.26%
Inventory $5.260M $4.764M $4.760M
Prepaid Expenses
Receivables $5.680M $3.409M $3.410M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $29.05M $25.17M $25.17M
YoY Change 15.42% -7.38% -7.4%
LONG-TERM ASSETS
Property, Plant & Equipment $510.0K $473.3K $470.0K
YoY Change 8.51% 0.29% 0.0%
Goodwill
YoY Change
Intangibles $62.91K
YoY Change 7.74%
Long-Term Investments $710.0K $2.190M $2.190M
YoY Change -67.58% -28.2% -28.2%
Other Assets $8.530M $8.920M $8.920M
YoY Change -4.37% 0.0% 0.0%
Total Long-Term Assets $9.810M $11.64M $11.64M
YoY Change -15.72% -6.83% -6.81%
TOTAL ASSETS
Total Short-Term Assets $29.05M $25.17M $25.17M
Total Long-Term Assets $9.810M $11.64M $11.64M
Total Assets $38.86M $36.81M $36.81M
YoY Change 5.57% -7.2% -7.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.110M $574.6K $570.0K
YoY Change 94.74% -18.38% -18.57%
Accrued Expenses $2.170M $1.503M $870.0K
YoY Change 149.43% 72.65% 6.1%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change
Total Short-Term Liabilities $3.670M $2.078M $2.080M
YoY Change 76.44% 31.95% 32.48%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00 $165.0K $170.0K
YoY Change -100.0% 11.55% 13.33%
Total Long-Term Liabilities $0.00 $165.0K $170.0K
YoY Change -100.0% 11.55% 13.33%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.670M $2.078M $2.080M
Total Long-Term Liabilities $0.00 $165.0K $170.0K
Total Liabilities $3.670M $2.243M $2.240M
YoY Change 63.84% 30.2% 30.23%
SHAREHOLDERS EQUITY
Retained Earnings -$51.90M
YoY Change 4.5%
Common Stock $318.00
YoY Change -3.34%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $35.18M $34.57M $34.57M
YoY Change
Total Liabilities & Shareholders Equity $38.86M $36.81M $36.81M
YoY Change 5.57% -7.2% -7.21%

Cashflow Statement

Concept 2017 2016 Q3 2016
OPERATING ACTIVITIES
Net Income -$876.8K -$510.0K -$1.282M
YoY Change -31.59% -105.69% -113.23%
Depreciation, Depletion And Amortization $153.3K $40.00K $160.9K
YoY Change -4.76% -33.33% -30.74%
Cash From Operating Activities -$666.8K -$1.330M -$1.149M
YoY Change -41.97% -275.0% -920.78%
INVESTING ACTIVITIES
Capital Expenditures $182.3K $0.00 $162.3K
YoY Change 12.32% -100.0% -52.85%
Acquisitions
YoY Change
Other Investing Activities $50.00K -$750.0K -$830.0K
YoY Change -106.02% -270.45% -80.7%
Cash From Investing Activities -$129.1K -$750.0K -$999.4K
YoY Change -87.09% -302.7% -78.51%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00 $1.748M
YoY Change -100.0% 11.75%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 133.0K 0.000 -2.701M
YoY Change -104.92% -100.0% 154.8%
NET CHANGE
Cash From Operating Activities -666.8K -1.330M -1.149M
Cash From Investing Activities -129.1K -750.0K -999.4K
Cash From Financing Activities 133.0K 0.000 -2.701M
Net Change In Cash -662.8K -2.080M -4.849M
YoY Change -86.33% -485.19% -12.94%
FREE CASH FLOW
Cash From Operating Activities -$666.8K -$1.330M -$1.149M
Capital Expenditures $182.3K $0.00 $162.3K
Free Cash Flow -$849.1K -$1.330M -$1.311M
YoY Change -35.25% -260.24% 542.02%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q3 lrad Accrued Contractcosts
AccruedContractcosts
197034
CY2016Q3 lrad Accrued Contractcosts
AccruedContractcosts
197034
CY2011Q1 lrad Amortization Period Of Prepaid Maintenance Agreement
AmortizationPeriodOfPrepaidMaintenanceAgreement
P8Y
CY2011Q4 lrad Area Of Leased Facility
AreaOfLeasedFacility
31360
CY2017Q3 lrad Deferred Revenue For Collection Issues
DeferredRevenueForCollectionIssues
0
CY2016Q3 lrad Deferred Revenue For Collection Issues
DeferredRevenueForCollectionIssues
0
CY2017Q3 lrad Deferred Tax Liabilities State Taxes Deduction
DeferredTaxLiabilitiesStateTaxesDeduction
7000
CY2016Q3 lrad Deferred Tax Liabilities State Taxes Deduction
DeferredTaxLiabilitiesStateTaxesDeduction
7000
CY2017 lrad Expired Net Operating Loss Carryforwards
ExpiredNetOperatingLossCarryforwards
283000
CY2016 lrad Expired Net Operating Loss Carryforwards
ExpiredNetOperatingLossCarryforwards
487000
CY2017 lrad Income Tax Reconciliation Change In Research And Development Carryover
IncomeTaxReconciliationChangeInResearchAndDevelopmentCarryover
-98000
CY2016 lrad Income Tax Reconciliation Change In Research And Development Carryover
IncomeTaxReconciliationChangeInResearchAndDevelopmentCarryover
-98000
CY2017 lrad Increase Decrease In Warranty Settlements
IncreaseDecreaseInWarrantySettlements
67959
CY2016 lrad Increase Decrease In Warranty Settlements
IncreaseDecreaseInWarrantySettlements
38588
CY2017 lrad Incresase In Accounts Receivable Stock Options Exercised
IncresaseInAccountsReceivableStockOptionsExercised
240228
CY2017 lrad Inventory Obsolescence Write Down Recoveries
InventoryObsolescenceWriteDownRecoveries
26243
CY2016 lrad Inventory Obsolescence Write Down Recoveries
InventoryObsolescenceWriteDownRecoveries
159954
CY2017 lrad Investments Typical Final Maturity
InvestmentsTypicalFinalMaturity
P3Y
CY2017 lrad Investments Typical Portfolio Weighted Average Maturity
InvestmentsTypicalPortfolioWeightedAverageMaturity
P1Y180D
CY2017 lrad Nondeductible Compensation Interest Expense And Other
NondeductibleCompensationInterestExpenseAndOther
21000
CY2016 lrad Nondeductible Compensation Interest Expense And Other
NondeductibleCompensationInterestExpenseAndOther
99000
CY2017Q3 lrad Number Of Major Customers Accounted For Accounts Receivable
NumberOfMajorCustomersAccountedForAccountsReceivable
3
CY2016Q3 lrad Number Of Major Customers Accounted For Accounts Receivable
NumberOfMajorCustomersAccountedForAccountsReceivable
3
CY2017 lrad Operating Leases Average Monthly Payments Due Current
OperatingLeasesAverageMonthlyPaymentsDueCurrent
16306
CY2017 lrad Operating Leases Average Monthly Payments Due In Fifth Year
OperatingLeasesAverageMonthlyPaymentsDueInFifthYear
29792
CY2017 lrad Operating Leases Average Monthly Payments Due In Fourth Year
OperatingLeasesAverageMonthlyPaymentsDueInFourthYear
28224
CY2017 lrad Operating Leases Average Monthly Payments Due In Second Year
OperatingLeasesAverageMonthlyPaymentsDueInSecondYear
25088
CY2017 lrad Operating Leases Average Monthly Payments Due In Sixth Year
OperatingLeasesAverageMonthlyPaymentsDueInSixthYear
31360
CY2017 lrad Operating Leases Average Monthly Payments Due In Third Year
OperatingLeasesAverageMonthlyPaymentsDueInThirdYear
26656
CY2017 lrad Product Warranty Accrual Increase Decrease For New Warranties Issuance And Adjustment Preexisting Warranties
ProductWarrantyAccrualIncreaseDecreaseForNewWarrantiesIssuanceAndAdjustmentPreexistingWarranties
-109925
CY2016 lrad Product Warranty Accrual Increase Decrease For New Warranties Issuance And Adjustment Preexisting Warranties
ProductWarrantyAccrualIncreaseDecreaseForNewWarrantiesIssuanceAndAdjustmentPreexistingWarranties
79954
CY2017 lrad Product Warranty Expense Benefit
ProductWarrantyExpenseBenefit
-109924
CY2016 lrad Product Warranty Expense Benefit
ProductWarrantyExpenseBenefit
79954
CY2017 lrad Product Warranty Period
ProductWarrantyPeriod
P1Y
CY2017 lrad Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate
0.1
CY2016 lrad Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate
0.1
CY2017 lrad Sustained Profitability Number Of Years
SustainedProfitabilityNumberOfYears
P6Y
CY2017Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1112366
CY2016Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
574566
CY2017Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5681882
CY2016Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3408912
CY2017Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2561395
CY2016Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1503044
CY2017Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1654194
CY2016Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1533079
CY2017Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1269
CY2016Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1549
CY2017Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
87956839
CY2016Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
86467215
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
605426
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1116400
CY2017 us-gaap Advertising Expense
AdvertisingExpense
42232
CY2016 us-gaap Advertising Expense
AdvertisingExpense
66353
CY2017 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1116400
CY2016 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
605426
CY2017Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2016Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2017 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7216
CY2016 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6752
CY2017Q3 us-gaap Assets
Assets
38857800
CY2016Q3 us-gaap Assets
Assets
36813533
CY2017Q3 us-gaap Assets Current
AssetsCurrent
29085867
CY2016Q3 us-gaap Assets Current
AssetsCurrent
25171294
CY2017Q3 us-gaap Capital Lease Obligations
CapitalLeaseObligations
0
CY2016Q3 us-gaap Capital Lease Obligations
CapitalLeaseObligations
0
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13466711
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18316103
CY2017Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12803887
CY2017 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-662824
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-4849392
CY2017Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
CY2016 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.03
CY2017Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2016Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2017Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2016Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2017Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32158436
CY2016Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31800103
CY2017Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32158436
CY2016Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31800103
CY2017Q3 us-gaap Common Stock Value
CommonStockValue
322
CY2016Q3 us-gaap Common Stock Value
CommonStockValue
318
CY2017 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-876474
CY2016 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1282847
CY2017 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">CONCENTRATION OF CREDIT RISK </div></div> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24.5pt;">The Company sells its products to a large number of geographically diverse customers. The Company routinely assesses the financial strength of its customers and generally does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> require collateral or other security to support customer receivables. At <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September</div><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> accounts receivable from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> customers accounted for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31%,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">22%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14%</div> of total accounts receivable with <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> other single customer accounting for more than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> of the accounts receivable balance. At <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> accounts receivable from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> customers accounted for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">27%,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">24%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12%</div> of total accounts receivable with <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> other single customer accounting for more than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> of the accounts receivable balance. </div></div> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24.5pt;">The Company maintains cash and cash equivalent accounts with Federal Deposit Insurance Corporation (&#x201c;FDIC&#x201d;) insured financial institutions. <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">The Company places its cash investments in instruments that meet high credit quality standards, as specified in our investment policy guidelines such as money market funds, corporate bonds, municipal bonds and Certificates of Deposit. These guidelines also limit the amount of credit exposure to any <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> issue, issuer or type of instrument. It is generally the Company&#x2019;s policy to invest in instruments that have a final maturity of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> longer than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> years</div><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">, with a portfolio weighted average maturity of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> longer than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18</div> months</div><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">.</div></div></div></div>
CY2017 us-gaap Cost Of Revenue
CostOfRevenue
10035577
CY2016 us-gaap Cost Of Revenue
CostOfRevenue
8689484
CY2017 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
CY2016 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
CY2017 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
1600
CY2016 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
1840
CY2017 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
1600
CY2016 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
1840
CY2017 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
166600
CY2016 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-159800
CY2017 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
196000
CY2016 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-188000
CY2017 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
196000
CY2016 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-188000
CY2017Q3 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
46101
CY2016Q3 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
CY2017Q3 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
CY2016Q3 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
93456
CY2017Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
268580
CY2016Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
637763
CY2017 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
29400
CY2016 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-28200
CY2017Q3 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
69000
CY2016Q3 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
102000
CY2017Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
20637000
CY2016Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
20636000
CY2017Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
8331000
CY2017Q3 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
8331000
CY2016Q3 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
8527000
CY2017Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
8331000
CY2016Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
8527000
CY2017Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
16443000
CY2016Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
16410000
CY2017Q3 us-gaap Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax
DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax
52000
CY2016Q3 us-gaap Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax
DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax
52000
CY2017Q3 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
2559000
CY2017Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
12306000
CY2016Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
12109000
CY2017Q3 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
80000
CY2016Q3 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
23000
CY2016Q3 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
2461000
CY2017Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
898000
CY2016Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
598000
CY2017Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
546000
CY2016Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
832000
CY2017Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
157000
CY2016Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
211000
CY2017 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
196239
CY2016 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
157081
CY2017 us-gaap Depreciation
Depreciation
146067
CY2016 us-gaap Depreciation
Depreciation
160941
CY2017 us-gaap Depreciation And Amortization
DepreciationAndAmortization
153283
CY2016 us-gaap Depreciation And Amortization
DepreciationAndAmortization
167693
CY2016 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
954650
CY2017 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2016 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2017 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
CY2016 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
CY2017 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2016 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2017Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1870579
CY2016Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
382845
CY2017 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
72709
CY2016 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
288
CY2017Q3 us-gaap Extended Product Warranty Accrual Noncurrent
ExtendedProductWarrantyAccrualNoncurrent
CY2016Q3 us-gaap Extended Product Warranty Accrual Noncurrent
ExtendedProductWarrantyAccrualNoncurrent
71582
CY2017 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P15Y
CY2017Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
52558
CY2016Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
45342
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
25841
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
6535
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
5506
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
5636
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
5924
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
6247
CY2016 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1292589
CY2017 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-416538
CY2016 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
556278
CY2017Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
108247
CY2016Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
108247
CY2017Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
55689
CY2016Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
62905
CY2017 us-gaap Gross Profit
GrossProfit
10278601
CY2016 us-gaap Gross Profit
GrossProfit
7671521
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-679154
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1467759
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
197600
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-186160
CY2017 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
197000
CY2016 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-66000
CY2017 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-231000
CY2016 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-499000
CY2017 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
1600
CY2016 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
1840
CY2017 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
48000
CY2016 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
-75000
CY2017 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-24000
CY2016 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-36000
CY2017 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
537800
CY2016 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-129376
CY2017 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2272970
CY2017 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
147456
CY2016 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
29972
CY2017 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
1487734
CY2016 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
51929
CY2017 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
519568
CY2016 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2309
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-226937
CY2016 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-187484
CY2017Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
55689
CY2016Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
62905
CY2017Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1742960
CY2016Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
775628
CY2017Q3 us-gaap Inventory Gross
InventoryGross
5675766
CY2016Q3 us-gaap Inventory Gross
InventoryGross
5344041
CY2017Q3 us-gaap Inventory Net
InventoryNet
5257234
CY2016Q3 us-gaap Inventory Net
InventoryNet
4763909
CY2017Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
3784935
CY2016Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
4393928
CY2017Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
418532
CY2016Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
580132
CY2017Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
147871
CY2016Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
174485
CY2017Q3 us-gaap Liabilities
Liabilities
3673761
CY2016Q3 us-gaap Liabilities
Liabilities
2242648
CY2017Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
38857800
CY2016Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
36813533
CY2017Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3673761
CY2016Q3 us-gaap Liabilities Current
LiabilitiesCurrent
2077610
CY2017Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
4359542
CY2016Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
2936124
CY2017Q3 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
711124
CY2016Q3 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
2187536
CY2017 us-gaap Nature Of Operations
NatureOfOperations
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.</div> OPERATIONS </div></div> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24.5pt;">LRAD Corporation, a Delaware corporation (the &#x201c;Company&#x201d;), is engaged in design, development and commercialization of directed <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">and omnidirectional sound technologies and products. The principal markets for the Company&#x2019;s proprietary sound reproduction technologies and products are in North and South America, Europe, Middle East and Asia. </div></div></div>
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
133000
CY2016 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2700906
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-129052
CY2016 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-999389
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-666772
CY2016 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1149097
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-876754
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-1281599
CY2017 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-876754
CY2016 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1281599
CY2017 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2017 us-gaap Operating Expenses
OperatingExpenses
11086341
CY2016 us-gaap Operating Expenses
OperatingExpenses
9264777
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-807740
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-1593256
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
330531
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
298797
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
15177
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
16557
CY2017 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
351418
CY2016 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
377033
CY2017 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
CY2016 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1748456
CY2017 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
0
CY2016Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2017 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
280
CY2016 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1248
CY2017 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
280
CY2016 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1248
CY2017Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
CY2016Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
165038
CY2017 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
128586
CY2016 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
125497
CY2016 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
954650
CY2017 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
CY2016 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
11272
CY2017 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
2908093
CY2016 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
825795
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
182326
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
162322
CY2017Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2017Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2016Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2017Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2016Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2016Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2017Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
983322
CY2016Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
595638
CY2017Q3 us-gaap Prepaid Expense And Other Assets Noncurrent
PrepaidExpenseAndOtherAssetsNoncurrent
164517
CY2016Q3 us-gaap Prepaid Expense And Other Assets Noncurrent
PrepaidExpenseAndOtherAssetsNoncurrent
391454
CY2017 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">RECLASSIFICATIONS</div><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></div> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24.5pt;">Where necessary, the prior year<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">&#x2019;s information has been reclassified to conform to the fiscal year <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> statement presentation. These reclassifications had <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> effect on previously reported results of operations or accumulated deficit. </div></div></div></div>
CY2017 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
2961367
CY2016 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
CY2017 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
373228
CY2016 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2200
CY2017Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
179101
CY2016Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
356984
CY2015Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
315618
CY2017Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
179101
CY2016Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
285402
CY2017 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
67958
CY2016 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
38588
CY2017Q3 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
-203000
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3329437
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.25
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
72709
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
288
CY2017Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2163797
CY2016Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2006423
CY2017 us-gaap Property Plant And Equipment Impairment
PropertyPlantAndEquipmentImpairment
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">IMPAIRMENT OF LONG-LIVED ASSETS </div></div> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24.5pt;">Long-lived assets and identifiable intangibles held for use are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> be recoverable. If the sum of undiscounted expected future cash flows is less than the carrying amount of the asset, or if changes in facts and circumstances indicate this, an impairment loss is measured and recognized using the asset<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">&#x2019;s fair value. </div></div></div></div>
CY2017Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
509603
CY2016Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
473344
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2500053
CY2016 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2387985
CY2017Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
39406
CY2016Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
39406
CY2017Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-52771853
CY2016Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-51895099
CY2016Q3 us-gaap Stockholders Equity
StockholdersEquity
34570885
CY2015Q3 us-gaap Stockholders Equity
StockholdersEquity
37949212
CY2017 us-gaap Revenues
Revenues
20314178
CY2016 us-gaap Revenues
Revenues
16361005
CY2017 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
19247020
CY2016 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
15305942
CY2017 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
1067158
CY2016 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
1055063
CY2017 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8586288
CY2016 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6876792
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
1116400
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
605426
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
81667
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
574500
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.71
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.70
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
869955
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4404002
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4663502
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.18
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.16
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.60
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
2.51
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.09
CY2017 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
0.93
CY2017Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
3329437
CY2017Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
4663502
CY2017 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
3.17
CY2017Q3 us-gaap Share Price
SharePrice
2.13
CY2017Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
673225
CY2017Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
2.25
CY2017Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
2.18
CY2017 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P3Y149D
CY2017 us-gaap Shipping And Handling Revenue
ShippingAndHandlingRevenue
124141
CY2016 us-gaap Shipping And Handling Revenue
ShippingAndHandlingRevenue
78975
CY2017 us-gaap Shipping Handling And Transportation Costs
ShippingHandlingAndTransportationCosts
148862
CY2016 us-gaap Shipping Handling And Transportation Costs
ShippingHandlingAndTransportationCosts
128380
CY2017 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
233333
CY2016 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1250
CY2017 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
1
CY2016 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2200
CY2017 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
373227
CY2016 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
1748456
CY2017Q3 us-gaap Stockholders Equity
StockholdersEquity
35184039
CY2017 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">USE OF ESTIMATES </div></div> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24.5pt;">The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions (e.g., share-based compensation valuation, valuation of inventory and intangible assets, warranty reserve, accrued bonus and valuation allowance related to deferred tax assets) that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities at the date of the financial statements and affect the reported amounts of revenues and expenses during the reporting period<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">s. Actual results could materially differ from those estimates. </div></div></div></div>
CY2017 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
31855430
CY2016 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
31970600
CY2017 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31855430
CY2016 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31970600

Files In Submission

Name View Source Status
0001437749-17-020614-index-headers.html Edgar Link pending
0001437749-17-020614-index.html Edgar Link pending
0001437749-17-020614.txt Edgar Link pending
0001437749-17-020614-xbrl.zip Edgar Link pending
ex_101839.htm Edgar Link pending
ex_101840.htm Edgar Link pending
ex_101841.htm Edgar Link pending
ex_101843.htm Edgar Link pending
ex_101952.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
lrad-20170930.xml Edgar Link completed
lrad-20170930.xsd Edgar Link pending
lrad-20170930_cal.xml Edgar Link unprocessable
lrad-20170930_def.xml Edgar Link unprocessable
lrad-20170930_lab.xml Edgar Link unprocessable
lrad-20170930_pre.xml Edgar Link unprocessable
lrad20170930_10k.htm Edgar Link pending
lrad20170930_10kimg001.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending